List of Tables
Table 1. Global Fidaxomicin Market Value Comparison by Type (2023-2029) & (US$ Million)
Table 2. Global Fidaxomicin Market Value Comparison by Application (2023-2029) & (US$ Million)
Table 3. Global Fidaxomicin Market Competitive Situation by Manufacturers in 2022
Table 4. Global Fidaxomicin Sales (K Tablets) of Key Manufacturers (2018-2023)
Table 5. Global Fidaxomicin Sales Market Share by Manufacturers (2018-2023)
Table 6. Global Fidaxomicin Revenue (US$ Million) by Manufacturers (2018-2023)
Table 7. Global Fidaxomicin Revenue Share by Manufacturers (2018-2023)
Table 8. Global Market Fidaxomicin Average Price (USD/ Tablets) of Key Manufacturers (2018-2023)
Table 9. Global Key Players of Fidaxomicin, Industry Ranking, 2021 VS 2022 VS 2023
Table 10. Global Key Manufacturers of Fidaxomicin, Manufacturing Sites & Headquarters
Table 11. Global Key Manufacturers of Fidaxomicin, Product Type & Application
Table 12. Global Key Manufacturers of Fidaxomicin, Date of Enter into This Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Fidaxomicin by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Fidaxomicin as of 2022)
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Fidaxomicin Market Size by Region (US$ Million): 2018 VS 2022 VS 2029
Table 17. Global Fidaxomicin Sales by Region (2018-2023) & (K Tablets)
Table 18. Global Fidaxomicin Sales Market Share by Region (2018-2023)
Table 19. Global Fidaxomicin Sales by Region (2024-2029) & (K Tablets)
Table 20. Global Fidaxomicin Sales Market Share by Region (2024-2029)
Table 21. Global Fidaxomicin Revenue by Region (2018-2023) & (US$ Million)
Table 22. Global Fidaxomicin Revenue Market Share by Region (2018-2023)
Table 23. Global Fidaxomicin Revenue by Region (2024-2029) & (US$ Million)
Table 24. Global Fidaxomicin Revenue Market Share by Region (2024-2029)
Table 25. North America Fidaxomicin Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 26. North America Fidaxomicin Sales by Country (2018-2023) & (K Tablets)
Table 27. North America Fidaxomicin Sales by Country (2024-2029) & (K Tablets)
Table 28. North America Fidaxomicin Revenue by Country (2018-2023) & (US$ Million)
Table 29. North America Fidaxomicin Revenue by Country (2024-2029) & (US$ Million)
Table 30. Europe Fidaxomicin Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 31. Europe Fidaxomicin Sales by Country (2018-2023) & (K Tablets)
Table 32. Europe Fidaxomicin Sales by Country (2024-2029) & (K Tablets)
Table 33. Europe Fidaxomicin Revenue by Country (2018-2023) & (US$ Million)
Table 34. Europe Fidaxomicin Revenue by Country (2024-2029) & (US$ Million)
Table 35. Asia Pacific Fidaxomicin Revenue by Region: 2018 VS 2022 VS 2029 (US$ Million)
Table 36. Asia Pacific Fidaxomicin Sales by Region (2018-2023) & (K Tablets)
Table 37. Asia Pacific Fidaxomicin Sales by Region (2024-2029) & (K Tablets)
Table 38. Asia Pacific Fidaxomicin Revenue by Region (2018-2023) & (US$ Million)
Table 39. Asia Pacific Fidaxomicin Revenue by Region (2024-2029) & (US$ Million)
Table 40. Latin America Fidaxomicin Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 41. Latin America Fidaxomicin Sales by Country (2018-2023) & (K Tablets)
Table 42. Latin America Fidaxomicin Sales by Country (2024-2029) & (K Tablets)
Table 43. Latin America Fidaxomicin Revenue by Country (2018-2023) & (US$ Million)
Table 44. Latin America Fidaxomicin Revenue by Country (2024-2029) & (US$ Million)
Table 45. Middle East & Africa Fidaxomicin Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 46. Middle East & Africa Fidaxomicin Sales by Country (2018-2023) & (K Tablets)
Table 47. Middle East & Africa Fidaxomicin Sales by Country (2024-2029) & (K Tablets)
Table 48. Middle East & Africa Fidaxomicin Revenue by Country (2018-2023) & (US$ Million)
Table 49. Middle East & Africa Fidaxomicin Revenue by Country (2024-2029) & (US$ Million)
Table 50. Global Fidaxomicin Sales (K Tablets) by Type (2018-2023)
Table 51. Global Fidaxomicin Sales (K Tablets) by Type (2024-2029)
Table 52. Global Fidaxomicin Sales Market Share by Type (2018-2023)
Table 53. Global Fidaxomicin Sales Market Share by Type (2024-2029)
Table 54. Global Fidaxomicin Revenue (US$ Million) by Type (2018-2023)
Table 55. Global Fidaxomicin Revenue (US$ Million) by Type (2024-2029)
Table 56. Global Fidaxomicin Revenue Market Share by Type (2018-2023)
Table 57. Global Fidaxomicin Revenue Market Share by Type (2024-2029)
Table 58. Global Fidaxomicin Price (USD/ Tablets) by Type (2018-2023)
Table 59. Global Fidaxomicin Price (USD/ Tablets) by Type (2024-2029)
Table 60. Global Fidaxomicin Sales (K Tablets) by Application (2018-2023)
Table 61. Global Fidaxomicin Sales (K Tablets) by Application (2024-2029)
Table 62. Global Fidaxomicin Sales Market Share by Application (2018-2023)
Table 63. Global Fidaxomicin Sales Market Share by Application (2024-2029)
Table 64. Global Fidaxomicin Revenue (US$ Million) by Application (2018-2023)
Table 65. Global Fidaxomicin Revenue (US$ Million) by Application (2024-2029)
Table 66. Global Fidaxomicin Revenue Market Share by Application (2018-2023)
Table 67. Global Fidaxomicin Revenue Market Share by Application (2024-2029)
Table 68. Global Fidaxomicin Price (USD/ Tablets) by Application (2018-2023)
Table 69. Global Fidaxomicin Price (USD/ Tablets) by Application (2024-2029)
Table 70. Astellas Corporation Information
Table 71. Astellas Description and Business Overview
Table 72. Astellas Fidaxomicin Sales (K Tablets), Revenue (US$ Million), Price (USD/ Tablets) and Gross Margin (2018-2023)
Table 73. Astellas Fidaxomicin Product
Table 74. Astellas Recent Developments/Updates
Table 75. Merck Corporation Information
Table 76. Merck Description and Business Overview
Table 77. Merck Fidaxomicin Sales (K Tablets), Revenue (US$ Million), Price (USD/ Tablets) and Gross Margin (2018-2023)
Table 78. Merck Fidaxomicin Product
Table 79. Merck Recent Developments/Updates
Table 80. Optimer Pharmaceuticals Corporation Information
Table 81. Optimer Pharmaceuticals Description and Business Overview
Table 82. Optimer Pharmaceuticals Fidaxomicin Sales (K Tablets), Revenue (US$ Million), Price (USD/ Tablets) and Gross Margin (2018-2023)
Table 83. Optimer Pharmaceuticals Fidaxomicin Product
Table 84. Optimer Pharmaceuticals Recent Developments/Updates
Table 85. Rochem Corporation Information
Table 86. Rochem Description and Business Overview
Table 87. Rochem Fidaxomicin Sales (K Tablets), Revenue (US$ Million), Price (USD/ Tablets) and Gross Margin (2018-2023)
Table 88. Rochem Fidaxomicin Product
Table 89. Rochem Recent Developments/Updates
Table 90. Tecoland Corporation Information
Table 91. Tecoland Description and Business Overview
Table 92. Tecoland Fidaxomicin Sales (K Tablets), Revenue (US$ Million), Price (USD/ Tablets) and Gross Margin (2018-2023)
Table 93. Tecoland Fidaxomicin Product
Table 94. Tecoland Recent Developments/Updates
Table 95. BrightGene Bio-Medical Technology Corporation Information
Table 96. BrightGene Bio-Medical Technology Description and Business Overview
Table 97. BrightGene Bio-Medical Technology Fidaxomicin Sales (K Tablets), Revenue (US$ Million), Price (USD/ Tablets) and Gross Margin (2018-2023)
Table 98. BrightGene Bio-Medical Technology Fidaxomicin Product
Table 99. BrightGene Bio-Medical Technology Recent Developments/Updates
Table 100. Olon Corporation Information
Table 101. Olon Description and Business Overview
Table 102. Olon Fidaxomicin Sales (K Tablets), Revenue (US$ Million), Price (USD/ Tablets) and Gross Margin (2018-2023)
Table 103. Olon Fidaxomicin Product
Table 104. Olon Recent Developments/Updates
Table 105. Livzon Group Corporation Information
Table 106. Livzon Group Description and Business Overview
Table 107. Livzon Group Fidaxomicin Sales (K Tablets), Revenue (US$ Million), Price (USD/ Tablets) and Gross Margin (2018-2023)
Table 108. Livzon Group Fidaxomicin Product
Table 109. Livzon Group Recent Developments/Updates
Table 110. Key Raw Materials Lists
Table 111. Raw Materials Key Suppliers Lists
Table 112. Fidaxomicin Distributors List
Table 113. Fidaxomicin Customers List
Table 114. Fidaxomicin Market Trends
Table 115. Fidaxomicin Market Drivers
Table 116. Fidaxomicin Market Challenges
Table 117. Fidaxomicin Market Restraints
Table 118. Research Programs/Design for This Report
Table 119. Key Data Information from Secondary Sources
Table 120. Key Data Information from Primary Sources
List of Figures
Figure 1. Product Picture of Fidaxomicin
Figure 2. Global Fidaxomicin Market Value Comparison by Type (2023-2029) & (US$ Million)
Figure 3. Global Fidaxomicin Market Share by Type in 2022 & 2029
Figure 4. Purity:90% Product Picture
Figure 5. Purity:95% Product Picture
Figure 6. Others Product Picture
Figure 7. Global Fidaxomicin Market Value Comparison by Application (2023-2029) & (US$ Million)
Figure 8. Global Fidaxomicin Market Share by Application in 2022 & 2029
Figure 9. Hospital
Figure 10. Retail Pharmacies
Figure 11. Global Fidaxomicin Revenue, (US$ Million), 2018 VS 2022 VS 2029
Figure 12. Global Fidaxomicin Market Size (2018-2029) & (US$ Million)
Figure 13. Global Fidaxomicin Sales (2018-2029) & (K Tablets)
Figure 14. Global Fidaxomicin Average Price (USD/ Tablets) & (2018-2029)
Figure 15. Fidaxomicin Report Years Considered
Figure 16. Fidaxomicin Sales Share by Manufacturers in 2022
Figure 17. Global Fidaxomicin Revenue Share by Manufacturers in 2022
Figure 18. The Global 5 and 10 Largest Fidaxomicin Players: Market Share by Revenue in 2022
Figure 19. Fidaxomicin Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2018 VS 2022
Figure 20. Global Fidaxomicin Market Size by Region (US$ Million): 2018 VS 2022 VS 2029
Figure 21. North America Fidaxomicin Sales Market Share by Country (2018-2029)
Figure 22. North America Fidaxomicin Revenue Market Share by Country (2018-2029)
Figure 23. U.S. Fidaxomicin Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 24. Canada Fidaxomicin Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 25. Europe Fidaxomicin Sales Market Share by Country (2018-2029)
Figure 26. Europe Fidaxomicin Revenue Market Share by Country (2018-2029)
Figure 27. Asia Pacific Fidaxomicin Sales Market Share by Region (2018-2029)
Figure 28. Asia Pacific Fidaxomicin Revenue Market Share by Region (2018-2029)
Figure 29. Latin America Fidaxomicin Sales Market Share by Country (2018-2029)
Figure 30. Latin America Fidaxomicin Revenue Market Share by Country (2018-2029)
Figure 31. Middle East & Africa Fidaxomicin Sales Market Share by Country (2018-2029)
Figure 32. Middle East & Africa Fidaxomicin Revenue Market Share by Country (2018-2029)
Figure 33. Global Sales Market Share of Fidaxomicin by Type (2018-2029)
Figure 34. Global Revenue Market Share of Fidaxomicin by Type (2018-2029)
Figure 35. Global Fidaxomicin Price (USD/ Tablets) by Type (2018-2029)
Figure 36. Global Sales Market Share of Fidaxomicin by Application (2018-2029)
Figure 37. Global Revenue Market Share of Fidaxomicin by Application (2018-2029)
Figure 38. Global Fidaxomicin Price (USD/ Tablets) by Application (2018-2029)
Figure 39. Fidaxomicin Value Chain
Figure 40. Fidaxomicin Production Process
Figure 41. Channels of Distribution (Direct Vs Distribution)
Figure 42. Distributors Profiles
Figure 43. Bottom-up and Top-down Approaches for This Report
Figure 44. Data Triangulation
Figure 45. Key Executives Interviewed